Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), wit…

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated pharmaceutical company, announced today that the U.S. Food and ...
Capital Brief

Mayne Pharma's Cosette takeover saga could return to court as break fee dispute erupts

Mayne Pharma and Cosette Pharmaceuticals are on another collision course despite the implosion of their $600 million takeover ...
TipRanks on MSN

Mayne Pharma terminates agreement with Cosette over breaches

Mayne Pharma Group ( ($AU:MYX) ) just unveiled an announcement. Mayne Pharma has terminated its Scheme Implementation Deed (SID) with Cosette due ...

Termination of Proposed Acquisition of Mayne Pharma

Both parties' notices of termination follow a ruling from the Treasurer of Australia blocking the proposed transaction and the expiry of the end date under the Scheme Implementation Deed in November.
WFMZ-TV

Cosette Pharmaceuticals Announces the Acquisition of G&W Laboratories' Lincolnton, NC Finished Dosage Manufacturing Plant

BRIDGEWATER, N.J., Nov. 4, 2019 /PRNewswire/ -- Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products, announced today that it ...
Business Wire

Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1%

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for ...